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Background: Patients with paroxysmal atrial fibrillation (AF) experience a similar risk of embolization compared to patients with persistent AF. 
Although consensus guidelines call for anticoagulant therapy in those at risk for thromboembolism irrespective of AF classification, differences may 
exist in the appropriate treatment of AF patients in real-world practice.
methods: We identified patients with AF and intermediate to high thromboembolic risk (CHADS2 score ≥ 2) enrolled in the ACC NCDR-PINNACLE 
Registry between July, 2008 and June, 2012. Using hierarchical modified Poisson regression models adjusted for patient characteristics, we 
examined whether antithrombotic treatment differed between patients with paroxysmal versus persistent AF.
results: Of 62,018 identified patients, 46,458 (74.9%) had paroxysmal and 15,560 (25.1%) had persistent AF. Paroxysmal AF was associated with 
less frequent treatment with anticoagulant therapy (48.1% vs. 58.4%), more frequent treatment with antiplatelet therapy (34.2% vs. 24.2%), and 
failure to treat with any therapy (17.7% vs. 17.4%), in unadjusted and multivariable adjusted analyses (Figure). In subgroup analysis, younger age 
(<75 years) was associated with significantly less use of oral anticoagulation in paroxysmal versus persistent AF patients (p value for interaction 
<0.001).
conclusions: In a large, real-world cardiac outpatient population, paroxysmal AF patients were less likely to be prescribed appropriate 
anticoagulant therapy.
 
